Multi-institutional study of implantable defibrillator lead performance in children and young adults: results of the Pediatric Lead Extractability and Survival Evaluation (PLEASE) study
- PMID: 23694966
- DOI: 10.1161/CIRCULATIONAHA.112.001120
Multi-institutional study of implantable defibrillator lead performance in children and young adults: results of the Pediatric Lead Extractability and Survival Evaluation (PLEASE) study
Abstract
Background: Implantable cardioverter-defibrillator (ICD) therapy in children and congenital heart disease patients is hampered by poor long-term lead survival. Lead extraction is technically difficult and carries substantial morbidity. We sought to determine the outcomes of ICD leads in pediatric and congenital heart disease patients.
Methods and results: The Pediatric Lead Extractability and Survival Evaluation (PLEASE) is a 24-center international registry. Pediatric and congenital heart disease patients with ICD lead implantations from 2005 to 2010 were eligible. Study subjects comprised 878 ICD patients (44% congenital heart disease). Mean±SD age at implantation was 18.6±9.8 years. Of the 965 total leads, 54% were thin (≤7F), of which 57% were Fidelis, and 23% were coated with expanded polytetrafluoroethylene. There were 139 ICD lead failures (14%) in 132 patients (15%) at a mean lead age of 2.0±1.4 years, causing shocks in 53 patients (40%). Independent predictors of lead failure included younger implantation age and Fidelis leads. Actuarial analysis showed an incremental risk of lead failure with younger age at implantation: <8 years compared with >18 years (P=0.015). The actuarial yearly failure rate was 2.3% for non-Fidelis and 9.1% for Fidelis leads. Extraction was performed on 143 leads (80% thin, 7% expanded polytetrafluoroethylene coated), with lead age as the only independent predictor for advanced extraction techniques. There were 6 major extraction complications (4%) but no procedural mortality.
Conclusions: This study demonstrates that ICD leads in children and congenital heart disease patients have an age-related suboptimal performance, further compounded by a high failure rate of Fidelis leads. Advanced extraction techniques were common and correlated with older lead age.
Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00335036.
Keywords: congenital abnormalities; death, sudden; defibrillators, implantable; pediatrics.
Comment in
-
Learning from implantable cardioverter-defibrillator leads in children.Circulation. 2013 Jun 18;127(24):2370-1. doi: 10.1161/CIRCULATIONAHA.113.003344. Epub 2013 May 21. Circulation. 2013. PMID: 23694967 No abstract available.
Similar articles
-
Implantable cardioverter-defibrillator lead failure in children and young adults: a matter of lead diameter or lead design?J Am Coll Cardiol. 2014 Jan 21;63(2):133-40. doi: 10.1016/j.jacc.2013.09.033. Epub 2013 Oct 16. J Am Coll Cardiol. 2014. PMID: 24140671
-
Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics.J Cardiovasc Electrophysiol. 2004 Jan;15(1):72-6. doi: 10.1046/j.1540-8167.2004.03388.x. J Cardiovasc Electrophysiol. 2004. PMID: 15028076 Clinical Trial.
-
Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead.J Cardiovasc Electrophysiol. 2010 Jun 1;21(6):671-7. doi: 10.1111/j.1540-8167.2009.01683.x. Epub 2010 Jan 15. J Cardiovasc Electrophysiol. 2010. PMID: 20082653
-
Experience with implantable cardioverter-defibrillator therapy in grown-ups with congenital heart disease.Pacing Clin Electrophysiol. 2008 Feb;31 Suppl 1:S35-7. doi: 10.1111/j.1540-8159.2008.00953.x. Pacing Clin Electrophysiol. 2008. PMID: 18226033 Review.
-
Implantable cardioverter defibrillator-related complications in the pediatric population.Pacing Clin Electrophysiol. 2009 Jul;32 Suppl 2:S71-4. doi: 10.1111/j.1540-8159.2009.02389.x. Pacing Clin Electrophysiol. 2009. PMID: 19602168 Review.
Cited by
-
Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids).JAMA Cardiol. 2019 Sep 1;4(9):918-927. doi: 10.1001/jamacardio.2019.2861. JAMA Cardiol. 2019. PMID: 31411652 Free PMC article.
-
Comparison of complications and shocks in paediatric and young transvenous and subcutaneous implantable cardioverter-defibrillator patients.Neth Heart J. 2018 Dec;26(12):612-619. doi: 10.1007/s12471-018-1186-1. Neth Heart J. 2018. PMID: 30377940 Free PMC article.
-
Procedural outcome & risk prediction in young patients undergoing transvenous lead extraction-a GALLERY subgroup analysis.Front Cardiovasc Med. 2023 Sep 6;10:1251055. doi: 10.3389/fcvm.2023.1251055. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37745113 Free PMC article.
-
In-Hospital and Midterm Outcomes of Lead Extraction: A Single-Center Clinical Study.J Tehran Heart Cent. 2024 Jan;19(1):25-30. doi: 10.18502/jthc.v19i1.15533. J Tehran Heart Cent. 2024. PMID: 39712353 Free PMC article.
-
Expanding the Reach of Pediatric Transcatheter Pacing.J Innov Card Rhythm Manag. 2021 Apr 15;12(4):4487-4492. doi: 10.19102/icrm.2021.120408. eCollection 2021 Apr. J Innov Card Rhythm Manag. 2021. PMID: 33939789 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical